Poster Abstract Session:
213. All Things Ebola
Saturday, October 10, 2015: 12:30 PM-2:00 PM
Room: Poster Hall

Learning Objectives:


Tracks: Pediatric ID, Global ID, Adult ID

Preparedness, Evaluation and Care of Pediatric Persons under Investigation (PUI) for Ebola virus Disease (EVD):  Experience from a Pediatric Designated Care Facility
Roberta De Biasi, MD, MS, FIDSA, FPIDS ; Xiaoyan Song, PhD, MBBS ; Krista Cato, RN ; Tara Floyd, RN ; Linda Talley, MS, BSN, RN, NE-BC, ; Kathleen Gorman, RN ; Martha Parra, MSN, RN ; Venkat Shankar, MD ; Denice Cora-Bramble, MD, MBA ; Craig Sable, MD ; David Wessel, MD
Human Factors Evaluation to Identify Systems Factors to Improve Safety during Donning and Doffing Personal Protective Equipment (PPE) in Ebola Virus Disease Management Scenarios
Gregory Hallihan, MASc ; Justin Baers, MSc ; Katelyn Wiley, BSc ; Jan Davies, MSc MD ; Jaime Kaufman, PhD ; John Conly, MD ; Jeff Caird, PhD
  • EBV posterSept 25 final.pdf (39.4 kB)
  • Is it Just Bad Luck? Examining the Role of Random Chance in the Epidemiology of Ebola
    Eric Lofgren, MSPH, PhD ; Caitlin Rivers, PhD ; Bryan Lewis, MPH, PhD ; Madhav V. Marathe, PhD ; Meredith Wilson, MPH ; Jiangzhuo Chen, PhD ; Stephen Eubank, PhD
    The Spatial Distribution of Ebola Virus Disease (EVD) Cases in Liberia Using the National Surveillance Database — March – September, 2014
    Rebecca Merrill, PhD, MHS ; Luke Bawo, BPharm, MPH ; J Mike Mulbah, MPH, BSc., ASc ; Stephen Gbanyan, ASc, BSc Candidate ; Lucy Mcnamara, PhD, MS ; Erik Reaves, DO, MTM&H ; Rachel Idowu, MD, MPH ; Athalia Christie, MIA ; John Neatherlin, MPH ; Jordan Tappero, MD, MPH ; Carl Kinkade, MCRP, GISP ; Joel Montgomery, PhD
    Antiviral Activity of Gendine Gloves against Ebola Virus for Reducing Transmission in Ebola Treatment Settings
    Jason Comer, PhD ; Trevor Brasel, PhD ; Bersabeh Tigabu, DVM, Ph.D. ; Ruth Reitzel, MS ; Joel Rosenblatt, PhD ; Issam Raad, MD, FACP, FIDSA, FSHEA

    CME Credits:

    ACPE Credits:

    ACPE Number:

    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 7th with the exception of research findings presented at the IDWeek press conferences.